337 related articles for article (PubMed ID: 34203247)
41. Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy.
Thudium CS; Moscatelli I; Löfvall H; Kertész Z; Montano C; Bjurström CF; Karsdal MA; Schulz A; Richter J; Henriksen K
Calcif Tissue Int; 2016 Dec; 99(6):638-648. PubMed ID: 27541021
[TBL] [Abstract][Full Text] [Related]
42. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis.
Scimeca JC; Quincey D; Parrinello H; Romatet D; Grosgeorge J; Gaudray P; Philip N; Fischer A; Carle GF
Hum Mutat; 2003 Feb; 21(2):151-7. PubMed ID: 12552563
[TBL] [Abstract][Full Text] [Related]
43. Yeast V-ATPase complexes containing different isoforms of the 100-kDa a-subunit differ in coupling efficiency and in vivo dissociation.
Kawasaki-Nishi S; Nishi T; Forgac M
J Biol Chem; 2001 May; 276(21):17941-8. PubMed ID: 11278748
[TBL] [Abstract][Full Text] [Related]
44. Refined genomic localization of the genetic lesion in the osteopetrosis (op) rat and exclusion of three positional and functional candidate genes, Clcn7, Atp6v0c, and Slc9a3r2.
Perdu B; Odgren PR; Van Wesenbeeck L; Jennes K; Mackay CC; Van Hul W
Calcif Tissue Int; 2009 May; 84(5):355-60. PubMed ID: 19259722
[TBL] [Abstract][Full Text] [Related]
45. Human osteopetroses and the osteoclast V-H+-ATPase enzyme system.
Ogbureke KU; Zhao Q; Li YP
Front Biosci; 2005 Sep; 10():2940-54. PubMed ID: 15970548
[TBL] [Abstract][Full Text] [Related]
46. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
47. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.
Lees RL; Sabharwal VK; Heersche JN
Bone; 2001 Feb; 28(2):187-94. PubMed ID: 11182377
[TBL] [Abstract][Full Text] [Related]
48. Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis.
Toro EJ; Zuo J; Ostrov DA; Catalfamo D; Bradaschia-Correa V; Arana-Chavez V; Caridad AR; Neubert JK; Wronski TJ; Wallet SM; Holliday LS
J Biol Chem; 2012 May; 287(21):17894-17904. PubMed ID: 22474295
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
[TBL] [Abstract][Full Text] [Related]
50. Rational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.
Toro EJ; Ostrov DA; Wronski TJ; Holliday LS
Curr Protein Pept Sci; 2012 Mar; 13(2):180-91. PubMed ID: 22044158
[TBL] [Abstract][Full Text] [Related]
51. Novel mutations in the a3 subunit of vacuolar H(+)-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis.
Michigami T; Kageyama T; Satomura K; Shima M; Yamaoka K; Nakayama M; Ozono K
Bone; 2002 Feb; 30(2):436-9. PubMed ID: 11856654
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase
Esmail S; Kartner N; Yao Y; Kim JW; Reithmeier RAF; Manolson MF
J Biol Chem; 2018 Feb; 293(8):2787-2800. PubMed ID: 29311258
[TBL] [Abstract][Full Text] [Related]
53. Characterization of vacuolar-ATPase and selective inhibition of vacuolar-H(+)-ATPase in osteoclasts.
Yao G; Feng H; Cai Y; Qi W; Kong K
Biochem Biophys Res Commun; 2007 Jun; 357(4):821-7. PubMed ID: 17462591
[TBL] [Abstract][Full Text] [Related]
54. Arg-735 of the 100-kDa subunit a of the yeast V-ATPase is essential for proton translocation.
Kawasaki-Nishi S; Nishi T; Forgac M
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12397-402. PubMed ID: 11592980
[TBL] [Abstract][Full Text] [Related]
55. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
[TBL] [Abstract][Full Text] [Related]
56. Role of the Cytosolic Domain of the a3 Subunit of V-ATPase in the Interaction with Rab7 and Secretory Lysosome Trafficking in Osteoclasts.
Nakanishi-Matsui M; Matsumoto N; Sun-Wada GH; Wada Y
Biol Pharm Bull; 2024; 47(1):339-344. PubMed ID: 38296463
[TBL] [Abstract][Full Text] [Related]
57. Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation.
Toyomura T; Oka T; Yamaguchi C; Wada Y; Futai M
J Biol Chem; 2000 Mar; 275(12):8760-5. PubMed ID: 10722719
[TBL] [Abstract][Full Text] [Related]
58. V-ATPase subunit interactions: the long road to therapeutic targeting.
Kartner N; Manolson MF
Curr Protein Pept Sci; 2012 Mar; 13(2):164-79. PubMed ID: 22044155
[TBL] [Abstract][Full Text] [Related]
59. Autosomal recessive osteopetrosis: report of 41 novel mutations in the TCIRG1 gene and diagnostic implications.
Pangrazio A; Caldana ME; Lo Iacono N; Mantero S; Vezzoni P; Villa A; Sobacchi C
Osteoporos Int; 2012 Nov; 23(11):2713-8. PubMed ID: 22231430
[TBL] [Abstract][Full Text] [Related]
60. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis.
Beranger GE; Momier D; Rochet N; Quincey D; Guigonis JM; Samson M; Carle GF; Scimeca JC
J Bone Miner Res; 2006 Nov; 21(11):1757-69. PubMed ID: 17002555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
